4DMedical Limited (ASX:4DX) is a pioneering medical technology company specializing in advanced diagnostic imaging solutions. Leveraging its proprietary XV Technology® and Imbio Technology™, 4DMedical provides cutting-edge thoracic imaging that enhances physician  diagnoses and management of respiratory conditions. This non-invasive, contrast-free technique offers precision and detail, delivering comprehensive insights into lung function and health. As an ASX-listed entity, 4DMedical is committed to driving innovation in pulmonary care, improving patient outcomes, and transforming respiratory medicine through its state-of-the-art imaging capabilities and robust R&D initiatives.